Showing results (161-170 of 1,027) with videos related to

Sort By:
Pageof 103
Journal of Neurology|October 17, 2002
Low molecular weight heparin for deep vein thrombosis in glioma patientsFriederike Schmidt, Christoph Faul, Johannes Dichgans, et al.
Current Opinion in Neurology|October 5, 2011
Geriatric neuro-oncology: from mythology to biologyMichael Weller, Michael Platten, Patrick Roth, et al.
Acta Neuropathologica|January 20, 2007
PIK3CA alterations in primary (de novo) and secondary glioblastomasDaisuke Kita, Yasuhiro Yonekawa, Michael Weller, et al.
STAR Protocols|November 5, 2023
Protocol for the expansion of mouse immune effector cells for in vitro and in vivo studiesThomas Look, Hanna Meister, Michael Weller, et al.
Expert Opinion on Pharmacotherapy|April 8, 2016
Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectivesKatharina Seystahl, Dorothee Gramatzki, Patrick Roth, et al.
Neuro-Oncology|October 31, 2015
Immunosuppressive mechanisms in glioblastomaEdjah K Nduom, Michael Weller, Amy B Heimberger
Expert Review of Anticancer Therapy|October 25, 2013
Tumor-associated edema in brain cancer patients: pathogenesis and managementPatrick Roth, Luca Regli, Michaela Tonder, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 28, 2007
Mechanisms of resistance of human glioma cells to Apo2 ligand/TNF-related apoptosis-inducing ligandJohannes Rieger, Brigitte Frank, Michael Weller, et al.
Neuro-Oncology Advances|October 10, 2022
Programmed death ligand 1 gene silencing in murine glioma models reveals cell line-specific modulation of tumor growth in vivoEvelina Blomberg, Manuela Silginer, Patrick Roth, et al.
Nature Reviews. Clinical Oncology|April 13, 2018
Current state of immunotherapy for glioblastomaMichael Lim, Yuanxuan Xia, Chetan Bettegowda, et al.
Pageof 103